BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Arthur Klausner to be a panelist at the 12th Annual Drug Delivery Partnerships Conference in San Diego, CA
News | 01. 21. 2008
